droplet-based PCR Bio-Rad Laboratories, Stilla Technologies Settle IP Lawsuit Bio-Rad had alleged Stilla's Naica digital PCR system infringed on four patents held or licensed by the firm. 10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit 10x asked the US District Court for the Northern District of California to dismiss a suit, while another district court judge denied a 10x motion to dismiss. Stilla Technologies Launches High-Throughput Digital PCR Chip, Plans Six-Color System Premium The new chip enables the firm's digital PCR system to test up to 240 samples per day, and also uses lower volumes of sample input. Bio-Rad Shutters Former GnuBio Facility as Part of Digital Biology R&D Consolidation The company acquired GnuBio, which was developing a droplet-based sequencing platform, in 2014 for $39.7 million in cash and $10 million in contingent payments. Bio-Rad Q2 Revenues Fall 2 Percent The sales decline was largely due to a slowdown in productivity related to the recent launch of the company's global enterprise resource planning system in Western Europe. Sep 11, 2015 Droplet Size Used as qPCR Readout in Prototype Device to Detect Heart Infections Premium May 11, 2015 Myriad Ramps Up Sample Prep Automation as it Moves Hereditary Cancer Testing to MyRisk NGS Panel Premium Apr 8, 2015 'Printing' 2D Droplet Arrays Enables Inexpensive Automated Single-Cell RT-qPCR Premium Jan 5, 2015 Arizona Researchers Developing Handheld PCR System for Ebola Detection Premium Feb 25, 2014 British Study Tests RainDrop Methylation Sequencing Method at Nanogram Sample Sizes Premium Jan 16, 2014 Droplet Digital PCR Shows Lower Limits of Detection, Quantification for BCR-ABL Testing Premium Nov 14, 2013 Bio-Rad Study Demonstrates EvaGreen-based Digital Droplet PCR and Multiplex Applications Premium Dec 6, 2012 U of Arizona Startup Developing Ultrafast Droplet PCR Method for Blood Infection, Veterinary Dx Premium Feb 28, 2012 Targeting Launch of Platform by Year's End, GnuBio Bets on Gene Panels, Replacing Sanger Assays Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.